X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
3.310
-0.030 (-0.90%)
May 13, 2025, 4:00 PM - Market closed

X4 Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2016 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Net Income
14.6-37.45-101.17-93.87-88.7-62.13
Upgrade
Depreciation & Amortization
1.210.80.420.510.50.35
Upgrade
Other Amortization
0.830.860.930.920.760.53
Upgrade
Loss (Gain) From Sale of Assets
-105-105----
Upgrade
Asset Writedown & Restructuring Costs
----9.76-
Upgrade
Stock-Based Compensation
6.988.28.695.26.185.43
Upgrade
Other Operating Activities
-25.6-0.98-5.724.42.11.07
Upgrade
Change in Accounts Receivable
-0.51-1.07----
Upgrade
Change in Inventory
-3.09-2.82----
Upgrade
Change in Accounts Payable
2.19-0.291.233.431.171.03
Upgrade
Change in Other Net Operating Assets
-3.096.85-0.892.31-2.66-5.09
Upgrade
Operating Cash Flow
-109.67-130.9-96.51-77.1-70.91-58.82
Upgrade
Capital Expenditures
-0.27-0.33-0.06-0.1-0.62-1.36
Upgrade
Sale of Property, Plant & Equipment
105105----
Upgrade
Sale (Purchase) of Intangibles
-10-7----
Upgrade
Investment in Securities
-25.56-30.68-14.82---
Upgrade
Investing Cash Flow
69.1766.99-14.88-0.1-0.62-1.36
Upgrade
Long-Term Debt Issued
-2022.5--12.39
Upgrade
Long-Term Debt Repaid
---2.06-0.8--
Upgrade
Net Debt Issued (Repaid)
202020.44-0.8-12.39
Upgrade
Issuance of Common Stock
0.290.2968.71122.8476.250.56
Upgrade
Repurchase of Common Stock
----0.01-2-0.28
Upgrade
Other Financing Activities
---0.63-4.8--0.28
Upgrade
Financing Cash Flow
20.2920.2988.52117.2374.2512.39
Upgrade
Foreign Exchange Rate Adjustments
-0.03-0.160.1-0.11-0.320.4
Upgrade
Net Cash Flow
-20.23-43.77-22.7839.922.41-47.38
Upgrade
Free Cash Flow
-109.94-131.23-96.57-77.21-71.52-60.18
Upgrade
Free Cash Flow Margin
-350.53%-5132.07%----2006.00%
Upgrade
Free Cash Flow Per Share
-16.28-19.58-16.29-36.46-83.33-89.92
Upgrade
Cash Interest Paid
7.777.774.63.012.912.1
Upgrade
Levered Free Cash Flow
-78.01-83.72-59.79-44.23-43.05-33.04
Upgrade
Unlevered Free Cash Flow
-73.15-79.09-57.1-42.65-41.53-31.9
Upgrade
Change in Net Working Capital
0.11-7.61-1.05-6.790.5-1.11
Upgrade
Updated May 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q